$32.42
0.000.00%
Pre-Market: 4:24 PM EDT
Comments
Loading...
Supernus Pharmaceuticals Stock Guidance | NASDAQ:SUPN | Benzinga
Supernus Pharmaceuticals issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 02/25/2025 | SUPN | Supernus Pharmaceuticals | FY | 2025 | — | — | — | $600.00M | $630.00M | $622.27M | Get Alert |
| 11/04/2024 | SUPN | Supernus Pharmaceuticals | FY | 2024 | — | — | — | $630.00M | $650.00M | $619.50M | Get Alert |
| 08/06/2024 | SUPN | Supernus Pharmaceuticals | FY | 2024 | — | — | — | $600.00M | $625.00M | $600.12M | Get Alert |
| 05/08/2024 | SUPN | Supernus Pharmaceuticals | FY | 2024 | — | — | — | $580.00M | $620.00M | $601.46M | Get Alert |
| 02/27/2024 | SUPN | Supernus Pharmaceuticals | FY | 2024 | — | — | — | $580.00M | $620.00M | $622.52M | Get Alert |
| 11/08/2023 | SUPN | Supernus Pharmaceuticals | FY | 2023 | — | — | — | $590.00M | $610.00M | $594.28M | Get Alert |
| 08/08/2023 | SUPN | Supernus Pharmaceuticals | FY | 2023 | — | — | — | $580.00M | $620.00M | $609.65M | Get Alert |
| 05/09/2023 | SUPN | Supernus Pharmaceuticals | FY | 2023 | — | — | — | $580.00M | $620.00M | $599.79M | Get Alert |
| 02/28/2023 | SUPN | Supernus Pharmaceuticals | FY | 2023 | — | — | — | $580.00M | $620.00M | $590.51M | Get Alert |
| 11/08/2022 | SUPN | Supernus Pharmaceuticals | FY | 2022 | — | — | — | $650.00M | $680.00M | $674.36M | Get Alert |
| 08/04/2022 | SUPN | Supernus Pharmaceuticals | FY | 2022 | — | — | — | $640.00M | $680.00M | $673.56M | Get Alert |
| 06/09/2022 | SUPN | Supernus Pharmaceuticals | FY | 2022 | — | — | — | $640.00M | $680.00M | $673.56M | Get Alert |
| 05/09/2022 | SUPN | Supernus Pharmaceuticals | FY | 2022 | — | — | — | $640.00M | $680.00M | $683.81M | Get Alert |
| 04/13/2022 | SUPN | Supernus Pharmaceuticals | FY | 2022 | — | — | — | $640.00M | $680.00M | $685.46M | Get Alert |
| 04/04/2022 | SUPN | Supernus Pharmaceuticals | FY | 2022 | — | — | — | $640.00M | $680.00M | $685.46M | Get Alert |
| 02/28/2022 | SUPN | Supernus Pharmaceuticals | Q4 | 2021 | — | — | — | $155.00M | $155.00M | $149.42M | Get Alert |
| 02/28/2022 | SUPN | Supernus Pharmaceuticals | FY | 2021 | — | — | — | $567.50M | $567.50M | $569.13M | Get Alert |
| 02/28/2022 | SUPN | Supernus Pharmaceuticals | FY | 2022 | — | — | — | $640.00M | $680.00M | $707.32M | Get Alert |
| 11/03/2021 | SUPN | Supernus Pharmaceuticals | FY | 2021 | — | — | — | $550.00M | $570.00M | $560.68M | Get Alert |
| 08/04/2021 | SUPN | Supernus Pharmaceuticals | FY | 2021 | — | — | — | $550.00M | $580.00M | $558.02M | Get Alert |
| 05/05/2021 | SUPN | Supernus Pharmaceuticals | FY | 2021 | — | — | — | $550.00M | $580.00M | $569.54M | Get Alert |
| 02/25/2021 | SUPN | Supernus Pharmaceuticals | FY | 2021 | — | — | — | $550.00M | $580.00M | $581.47M | Get Alert |
| 11/03/2020 | SUPN | Supernus Pharmaceuticals | FY | 2020 | — | — | — | $500.00M | $525.00M | $486.54M | Get Alert |
| 08/18/2020 | SUPN | Supernus Pharmaceuticals | FY | 2020 | — | — | — | $460.00M | $500.00M | $456.64M | Get Alert |
| 08/11/2020 | SUPN | Supernus Pharmaceuticals | Q2 | 2020 | — | — | — | $126.70M | $126.70M | $89.34M | Get Alert |
FAQ
What is the most recent guidance for Supernus Pharmaceuticals (SUPN)?
There have been no specific sales or earnings guidance reported for Supernus Pharmaceuticals in recent months.
Browse guidance and forecast on all stocks.